'An important moment for cycling': Chris Froome ready to 'move on' after UCI closes anti-doping case
The four-time Tour de France champion will line-up on July 7 for the 2018 race with his salbutamol case now closed
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Sign up to our newsletter Newsletter

Chris Froome says he's glad the long-running anti-doping case against him is finally over, and says his exoneration is an "important moment for cycling."
Since the latter part of 2017, Froome has had to face public scrutiny over an anti-doping case brought against him by the UCI for testing over the allowed limit for asthma drug salbutamol on stage 18 of the Vuelta a España.
>>> Chris Froome cleared by UCI in anti-doping investigation
As a 'presumed' Adverse Analytical Finding (AAF), the four-time Tour de France winner was allowed under UCI rules to explain his breach of the permissible limits in a confidential process.
After the case was leaked by newspapers Le Monde and the Guardian, Froome has faced a huge amount of questions and focus from the media.
However, after submitting evidence and an explanation in June, the World Anti-Doping Agency told the UCI it would accept the explanation and that Froome's test did not constitute an AAF.
The UCI cleared Froome on July 2, five days before the start of the 2018 Tour de France. The 33-year-old says he is "glad it's finally over" and that he "never doubted that this case would be dismissed."
“I am very pleased that the UCI has exonerated me," Froome said in a statement.
"While this decision is obviously a big deal for me and the Team, it’s also an important moment for cycling. I understand the history of this great sport – good and bad.
"I have always taken my leadership position very seriously and I always do things the right way. I meant it when I said that I would never dishonour a winner’s jersey and that my results would stand the test of time.
“I have never doubted that this case would be dismissed for the simple reason that I have known throughout I did nothing wrong. I have suffered with asthma since childhood. I know exactly what the rules are regarding my asthma medication and I only ever use my puffer to manage my symptoms within the permissible limits
“Of course, the UCI had to examine these test results from the Vuelta. Unfortunately, the details of the case did not remain confidential, as they should have done. And I appreciate more than anyone else the frustration at how long the case has taken to resolve and the uncertainty this has caused. I am glad it’s finally over.
“I am grateful for all the support I have had from the Team and from many fans across the world. Today’s ruling draws a line. It means we can all move on and focus on the Tour de France.”
In a long statement from Team Sky, which also included an explanation of the process since being notified of the finding in September 2017, team boss Dave Brailsford said that their total confidence in Froome being cleared was why they allowed him to continue racing. Froome and Sky faced numerous calls from high-profile figures to withdraw from racing until the case had been resolved.
Froome raced and won the Giro d'Italia in May to complete a Grand Tour hat-trick, holding the Tour, Vuelta and Giro title at the same time, with the aim to take his fifth Tour win in a few weeks.
Brailsford also provided more background to the case and said the Froome's "professionalism, integrity and good grace under pressure have been exemplary and a credit to the sport."
“We have always had total confidence in Chris and his integrity," Brailsford said.
"We knew that he had followed the right medical guidance in managing his asthma at the Vuelta and were sure that he would be exonerated in the end, which he has been. This is why we decided that it was right for Chris to continue racing, in line with UCI rules, while the process was ongoing. We are pleased that it has now been resolved.
“Chris’s elevated Salbutamol urine reading from stage 18 of the Vuelta was treated as a ‘presumed’ Adverse Analytical Finding (AAF) by the UCI and WADA, which triggered a requirement for us to provide further information. After a comprehensive review of that information, relevant data and scientific research, the UCI and WADA have concluded that there was, in fact, no AAF and that no rule has been broken.
“We said at the outset that there are complex medical and physiological issues which affect the metabolism and excretion of Salbutamol. The same individual can exhibit significant variations in test results taken over multiple days while using exactly the same amount of Salbutamol. This means that the level of Salbutamol in a single urine sample, alone, is not a reliable indicator of the amount inhaled. A review of all Chris’s 21 test results from the Vuelta revealed that the stage 18 result was within his expected range of variation and therefore consistent with him having taken a permitted dose of Salbutamol.
“Chris has proved he is a great champion – not only on the bike but also by how he has conducted himself during this period. It has not been easy, but his professionalism, integrity and good grace under pressure have been exemplary and a credit to the sport.
“The greatest bike race in the world starts in five days. We can’t wait to get racing again and help Chris win it for a record-equalling fifth time.”
The 2018 Tour de France begins on July 7 in Vendée.
Thank you for reading 10 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Follow on Twitter: @richwindy
Richard is digital editor of Cycling Weekly. Joining the team in 2013, Richard became editor of the website in 2014 and coordinates site content and strategy, leading the news team in coverage of the world's biggest races and working with the tech editor to deliver comprehensive buying guides, reviews, and the latest product news.
An occasional racer, Richard spends most of his time preparing for long-distance touring rides these days, or getting out to the Surrey Hills on the weekend on his Specialized Tarmac SL6 (with an obligatory pub stop of course).
-
-
'We can't get enough high-end road and gravel bikes,' says Sigma Sports founder
Market demand remains strong for premium bikes and e-bikes, according to retailer
By Tom Davidson • Published
-
Five dark horses for the men's Tour of Flanders 2023
Outside bets who could spring a surprise in 'De Ronde'
By Tom Thewlis • Published
-
‘It’s not complicated, I can either follow or I can’t’ - Tom Pidcock on his Tour of Flanders chances
Strade Bianche winner believes that his performance on Sunday won't be hampered by recent lack of racing time
By Tom Thewlis • Published
-
Tom Pidcock: 'It won’t be difficult to beat my 2022 Classics results'
Ineos Grenadiers' multi-format star ready for central role in one-day racing this Spring
By Adam Becket • Published
-
No Egan Bernal at Paris-Nice as knee injury disrupts season
Former Tour de France champion "OK" but return is unknown at the moment
By Adam Becket • Published
-
'Rough day' for Chris Froome after crash and punctures kill best chance of victory since 2018
The 37-year-old was up the road in a solo move for over 50km at the Tour du Rwanda on Thursday
By Adam Becket • Published
-
Global backers in talks over new British WorldTour team
Former management of Ribble Weldtite courting interest in new project
By Tom Thewlis • Published
-
'I remember the crowds more than anything': Tom Pidcock recalls his Alpe d'Huez Tour de France stage win
Our male rider of the year, Tom Pidcock, talks us through the highs and lows of his 2022 campaign
By Tom Thewlis • Published
-
Leo Hayter, Cycling Weekly's rising star of 2022, talks through his season in the spotlight
We caught up with the winner of the "Baby Giro" to hear all about the win in Italy and his dream move to Ineos Grenadiers
By Tom Thewlis • Published
-
Ineos Grenadiers release 'visibly fast' 2023 jersey
Navy is replaced with red as British team changes its look
By Adam Becket • Published